Bionical Solutions Group Limited
Bionical Solutions Group Limited, headquartered in Great Britain, is a leading provider in the life sciences sector, specialising in innovative solutions for the pharmaceutical and healthcare industries. Founded in 2015, the company has rapidly established itself as a key player, with a strong presence across Europe and North America. Bionical Solutions offers a range of services, including clinical trial support, patient recruitment, and market access strategies, all designed to enhance the efficiency of drug development. Their unique approach combines advanced technology with deep industry expertise, ensuring tailored solutions that meet the specific needs of their clients. With a commitment to quality and a focus on patient-centric outcomes, Bionical Solutions has achieved significant milestones, positioning itself as a trusted partner for global pharmaceutical companies. Their dedication to excellence continues to drive their growth and reputation in the competitive life sciences landscape.
DitchCarbon Score
How does Bionical Solutions Group Limited's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Medical Device Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
Bionical Solutions Group Limited's score of 7 is lower than 83% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Bionical Solutions Group Limited's reported carbon emissions
In 2022, Bionical Solutions Group Limited reported significant carbon emissions, with Scope 2 emissions amounting to approximately 24,348 kg CO2e and Scope 3 emissions reaching about 1,202,270,481 kg CO2e. Notably, the company recorded zero emissions for Scope 1, indicating no direct emissions from owned or controlled sources. Despite the substantial Scope 3 emissions, which typically encompass indirect emissions from the value chain, Bionical Solutions Group has not established specific reduction targets or initiatives as part of their climate commitments. The absence of documented reduction strategies suggests a need for further development in their sustainability efforts. Overall, while Bionical Solutions Group Limited has made strides in tracking their emissions, particularly in Scope 2, the lack of defined reduction targets highlights an opportunity for the company to enhance its climate action framework and contribute more effectively to global sustainability goals.
Unlock detailed emissions data
Access structured emissions data, company-specific emission factors, and source documents
Add to project| 2022 | |
|---|---|
| Scope 1 | - |
| Scope 2 | 24,348 |
| Scope 3 | 1,202,270,481 |
Industry emissions intensity
Location emissions intensity
Reduction initiatives & disclosure networks
Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.
Bionical Solutions Group Limited is not committed to any reduction initiatives we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.
